Silly Question: It it a good experiment to put the medicine in one eye and the placebo in the other eye? What could be other consequences of such a thing?

Should we invest in the company that makes them. What an amazing development

Novartis acquihired them very early on and now is performing clinical trials.

Results from the most recent completed study are encouraging:

https://www.healio.com/news/optometry/20201012/further-study...

Wow it really would be!